Evotec Expands AI Drug Discovery with Odyssey Partnership
Hamburg, Germany, August 8, 2026 Evotec SE has entered a strategic AI-enabled research and development collaboration with Odyssey Therapeutics...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Hamburg, Germany, August 8, 2026 Evotec SE has entered a strategic AI-enabled research and development collaboration with Odyssey Therapeutics...
Irving, Texas, USA, August 7, 2026 Caris Life Sciences has announced the publication of a new study demonstrating that...
SARASOTA, Fla., July 22, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced new preclinical resistance data supporting its lead antimicrobial candidate...
SALT LAKE CITY, April 2, 2026 Co-Diagnostics, Inc. announced that its joint venture CoMira Diagnostics has received approval to...
